Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.

van Rossum, J A; Looysen, E E; Daniels, J M A; Killestein, J

van Rossum, J A; Looysen, E E; Daniels, J M A; Killestein, J.

Affiliation

van Rossum JA; VU University Medical Center, Amsterdam, The Netherlands j.vanrossum@vumc.nl.
Looysen EE; VU University Medical Center, Amsterdam, The Netherlands.
Daniels JM; VU University Medical Center, Amsterdam, The Netherlands.
Killestein J; MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

Mult Scler ; 20(13): 1792-3, 2014 Nov.

Article in En | MEDLINE | ID: mdl-24866203

Subject(s)

Asthma/chemically induced; Multiple Sclerosis, Relapsing-Remitting/drug therapy; Propylene Glycols/adverse effects; Sphingosine/analogs & derivatives; Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents/adverse effects; Sphingosine/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propylene Glycols / Asthma / Sphingosine / Multiple Sclerosis, Relapsing-Remitting Limits: Adult / Female / Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2014 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google